Insmed
INSM
#908
Rank
โ‚น2.455 T
Marketcap
โ‚น11,194
Share price
-1.69%
Change (1 day)
-37.30%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น47.88 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น1.51 Billion. In 2025 the company made an earning of -โ‚น111.59 Billion a decrease over its 2024 earnings that were of -โ‚น77.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น47.88 Billion-57.1%
2025 -โ‚น111.59 Billion43.91%
2024 -โ‚น77.54 Billion23.71%
2023 -โ‚น62.68 Billion45.77%
2022 -โ‚น43 Billion15.83%
2021 -โ‚น37.13 Billion50.19%
2020 -โ‚น24.72 Billion16.4%
2019 -โ‚น21.24 Billion-23.9%
2018 -โ‚น27.91 Billion59.35%
2017 -โ‚น17.51 Billion8.52%
2016 -โ‚น16.14 Billion47.25%
2015 -โ‚น10.96 Billion34.53%
2014 -โ‚น8.15 Billion58.83%
2013 -โ‚น5.13 Billion35.14%
2012 -โ‚น3.8 Billion-31.92%
2011 -โ‚น5.58 Billion854.92%
2010 -โ‚น0.59 Billion-105.22%
2009 โ‚น11.17 B-905.06%
2008 -โ‚น1.39 Billion-27.31%
2007 -โ‚น1.91 Billion-62.41%
2006 -โ‚น5.09 Billion98.19%
2005 -โ‚น2.57 Billion0.03%
2004 -โ‚น2.57 Billion159.07%
2003 -โ‚น0.99 Billion-69.31%
2002 -โ‚น3.23 Billion
2000 -โ‚น2.91 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.181 T-2,520.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚น236.69 Billion 384.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น426.19 B-973.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.24 Billion-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.18 Billion-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น4.83 Billion-90.11%๐Ÿ‡บ๐Ÿ‡ธ USA